Product
Caelyx®
1 clinical trial
1 indication
Indication
Breast CancerClinical trial
CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer: a Feasibility Phase II TrialStatus: Active (not recruiting), Estimated PCD: 2023-12-31
1 clinical trial
1 indication